Correlation Between HUTCHMED DRC and Ironwood Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Ironwood Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Ironwood Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Ironwood Pharmaceuticals, you can compare the effects of market volatilities on HUTCHMED DRC and Ironwood Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Ironwood Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Ironwood Pharmaceuticals.

Diversification Opportunities for HUTCHMED DRC and Ironwood Pharmaceuticals

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between HUTCHMED and Ironwood is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Ironwood Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ironwood Pharmaceuticals and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Ironwood Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ironwood Pharmaceuticals has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Ironwood Pharmaceuticals go up and down completely randomly.

Pair Corralation between HUTCHMED DRC and Ironwood Pharmaceuticals

Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 0.71 times more return on investment than Ironwood Pharmaceuticals. However, HUTCHMED DRC is 1.41 times less risky than Ironwood Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Ironwood Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  1,653  in HUTCHMED DRC on September 14, 2024 and sell it today you would lose (66.00) from holding HUTCHMED DRC or give up 3.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HUTCHMED DRC  vs.  Ironwood Pharmaceuticals

 Performance 
       Timeline  
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Ironwood Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ironwood Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

HUTCHMED DRC and Ironwood Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HUTCHMED DRC and Ironwood Pharmaceuticals

The main advantage of trading using opposite HUTCHMED DRC and Ironwood Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Ironwood Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ironwood Pharmaceuticals will offset losses from the drop in Ironwood Pharmaceuticals' long position.
The idea behind HUTCHMED DRC and Ironwood Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk